Antimicrobial Resistance Profiling and Molecular Epidemiological Analysis of Extended Spectrum β-Lactamases Produced by Extraintestinal Invasive Escherichia coli Isolates From Ethiopia: The Presence of International High-Risk Clones ST131 and ST410 Revealed

Molecular characterization of Extended-spectrum β lactamase- producing E. coli recovered from community-acquired urinary tract infections in Upper Egypt

(2020) Noha A. Hassuna et al.   Scientific Reports

High Prevalence of CTX-M Type Extended-Spectrum Beta-Lactamase Genes and Detection of NDM-1 Carbapenemase Gene in Extraintestinal Pathogenic Escherichia coli in Cuba

(2020) Dianelys Quiñones et al.   Pathogens

Molecular Mechanisms, Epidemiology, and Clinical Importance of β-Lactam Resistance in Enterobacteriaceae

(2020) Giulia De Angelis et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia

(2019) Dejenie Shiferaw Teklu et al.   Antimicrobial Resistance and Infection Control

Emergence and dominance of E. coli ST131 CTX-M-27 in a community paediatric cohort study: independent host factors and bacterial genetic determinants

(2019) André Birgy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

β-Lactamases and β-Lactamase Inhibitors in the 21st Century

(2019) Catherine L. Tooke et al.   JOURNAL OF MOLECULAR BIOLOGY

Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages

(2019) Amee R. Manges et al.   CLINICAL MICROBIOLOGY REVIEWS

Systematic Review of Important Bacterial Zoonoses in Africa in the Last Decade in Light of the ‘One Health’ Concept

(2019) Jonathan Asante et al.   Pathogens

Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options

(2019) Gisele Peirano et al.   DRUGS

Multidrug-resistant profile and prevalence of extended spectrum β-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia

(2019) Degefu Beyene et al.   PLoS One

Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection

(2019) Brian M. Forde et al.   Nature Communications

The higher prevalence of extended spectrum beta-lactamases among Escherichia coli ST131 in Southeast Asia is driven by expansion of a single, locally prevalent subclone

(2019) Swaine L. Chen et al.   Scientific Reports

The EnteroBase user's guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity

(2019) Zhemin Zhou et al.   GENOME RESEARCH

Antimicrobial resistance among children in sub-Saharan Africa

(2018) Phoebe C M Williams et al.   LANCET INFECTIOUS DISEASES

First Report of an ST410 OXA-181 and CTX-M-15 Coproducing Escherichia coli Clone in Italy: A Whole-Genome Sequence Characterization

(2018) Aurora Piazza et al.   Microbial Drug Resistance

Comprehensive Molecular Characterization of Escherichia coli Isolates from Urine Samples of Hospitalized Patients in Rio de Janeiro, Brazil

(2018) Ana Carolina C. Campos et al.   Frontiers in Microbiology

Escherichia coli Sequence Type 410 Is Causing New International High-Risk Clones

(2018) Louise Roer et al.   mSphere

Prevalence and antibiotic susceptibility pattern of CTX-M type extended-spectrum β-lactamases among clinical isolates of gram-negative bacilli in Jimma, Ethiopia

(2018) Ahmed Zeynudin et al.   BMC INFECTIOUS DISEASES

Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran

(2017) Z. Hojabri et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype

(2017) Edward R. Bevan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany

(2017) Michael Pietsch et al.   VETERINARY MICROBIOLOGY

The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011–2012)

(2017) James R. Johnson et al.   Open Forum Infectious Diseases

Circulation of clonal populations of fluoroquinolone-resistant CTX-M-15-producing Escherichia coli ST410 in humans and animals in Germany

(2016) Linda Falgenhauer et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Interconnected microbiomes and resistomes in low-income human habitats

(2016) Erica C. Pehrsson et al.   NATURE

Escherichia coli β-Lactamases: What Really Matters

(2016) Priyanka Bajaj et al.   Frontiers in Microbiology

Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China

(2016) Su Wang et al.   PLoS One

First Report of OXA-181-Producing Escherichia coli in China and Characterization of the Isolate Using Whole-Genome Sequencing

(2015) Yanbin Liu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenicEscherichia colistrains isolated from patients with urinary tract infections in South Korea

(2015) J.H. Lee et al.   LETTERS IN APPLIED MICROBIOLOGY

Virulence Genotype and Phylogenetic Groups in relation to Chinese Herb Resistance among Escherichia Coli from Patients with acute Pyelonephritis

(2014) Y Tong et al.   African Journal of Traditional Complementary and Alternative Medicines

Characteristics of Escherichia coli Sequence Type 131 Isolates That Produce Extended-Spectrum β-Lactamases: Global Distribution of theH30-Rx Sublineage

(2014) Gisele Peirano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Escherichia coli ST131, an Intriguing Clonal Group

(2014) M.-H. Nicolas-Chanoine et al.   CLINICAL MICROBIOLOGY REVIEWS

Prevalence of β-Lactamase-Encoding Genes among Enterobacteriaceae Bacteremia Isolates Collected in 26 U.S. Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010)

(2013) Mariana Castanheira et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010

(2013) Ritu Banerjee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans

(2013) Aylin Colpan et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in Sweden 2007–2011

(2013) A. Brolund et al.   CLINICAL MICROBIOLOGY AND INFECTION

Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases

(2013) Ghizlane Dahbi et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Molecular epidemiology of extended-spectrum  -lactamase-, AmpC  -lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11

(2013) A. J. Denisuik et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria

(2013) Elizabeth MH Wellington et al.   LANCET INFECTIOUS DISEASES

Single or in Combination Antimicrobial Resistance Mechanisms of Klebsiella pneumoniae Contribute to Varied Susceptibility to Different Carbapenems

(2013) Yu-Kuo Tsai et al.   PLoS One

Prevalence and Molecular Characterization of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in a Pediatric Patient Population

(2012) Lakshmi Chandramohan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods

(2012) Alexandre P Francisco et al.   BMC BIOINFORMATICS

Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum- -lactamase-producing Escherichia coli in Japan

(2012) Y. Matsumura et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The ClermontEscherichia coliphylo-typing method revisited: improvement of specificity and detection of new phylo-groups

(2012) Olivier Clermont et al.   Environmental Microbiology Reports

CTX-M Enzymes: Origin and Diffusion

(2012) Rafael Cantón et al.   Frontiers in Microbiology

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Animal and human pathogenic Escherichia coli strains share common genetic backgrounds

(2011) Olivier Clermont et al.   INFECTION GENETICS AND EVOLUTION

Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae

(2010) Caroline Dallenne et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Characterization of Extended-Spectrum β-Lactamases Produced by Escherichia coli Isolated from Hospitalized and Nonhospitalized Patients: Emergence of CTX-M-15-Producing Strains Causing Urinary Tract Infections

(2010) Annemieke Smet et al.   Microbial Drug Resistance

The population genetics of commensal Escherichia coli

(2010) Olivier Tenaillon et al.   NATURE REVIEWS MICROBIOLOGY

Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004

(2009) J. R. Johnson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains

(2009) O. Clermont et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK

(2009) M. Doumith et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Multiresistant Enterobacteriaceae: new threat of an old problem

(2008) Johann DD Pitout   Expert Review of Anti-Infective Therapy